Daiwa Securities Group
JBIO icon

Daiwa Securities Group’s Jade Biosciences JBIO Stock Holding History

Daiwa Securities Group’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed -$1K – 1321
2022
Q3 		$1K Hold
2
– – ﹤0.01% 1272
2022
Q2 		$1K Hold
2
– – ﹤0.01% 1276
2022
Q1 		$1K Buy
+2
New +$776 ﹤0.01% 1294

Other funds holding JBIO

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Daiwa Securities Group's JBIO Position: Q4 2022 in Review

Daiwa Securities Group sold out of Jade Biosciences (JBIO) in Q4 2022, closing a stake of 2 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in JBIO in Q1 2022 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 68 funds tracked by Wall St. Rank hold JBIO as of Q4 2022.

  • Daiwa Securities Group reported no remaining Jade Biosciences position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 2 Jade Biosciences shares in Q4 2022, an estimated $1K.
  • Daiwa Securities Group first reported a position in Jade Biosciences in Q1 2022 and held it in 3 quarters.
  • Daiwa Securities Group's Jade Biosciences position peaked at $1K in Q3 2022.
  • 68 funds tracked by Wall St. Rank held Jade Biosciences as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.